These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32624662)

  • 1. Rectal indomethacin reduces the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis in low-risk patients.
    Abdelfatah MM; Gochanour E; Koutlas NJ; Hamed A; Harvin G; Othman MO
    Ann Gastroenterol; 2020; 33(4):405-411. PubMed ID: 32624662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography.
    Thiruvengadam NR; Forde KA; Ma GK; Ahmad N; Chandrasekhara V; Ginsberg GG; Ho IK; Jaffe D; Panganamamula KV; Kochman ML
    Gastroenterology; 2016 Aug; 151(2):288-297.e4. PubMed ID: 27215656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis.
    Garg R; Mohan BP; Krishnamoorthi R; Rustagi T
    Indian J Gastroenterol; 2018 Mar; 37(2):120-126. PubMed ID: 29619673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis.
    Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A
    Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus and Indomethacin Are Safe and Effective at Reducing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography in Patients Who Have Undergone Liver Transplantation.
    Thiruvengadam NR; Forde KA; Chandrasekhara V; Ahmad NA; Ginsberg GG; Khungar V; Kochman ML
    Clin Gastroenterol Hepatol; 2020 May; 18(5):1224-1232.e1. PubMed ID: 31622734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indomethacin down-regulating HMGB1 and TNF-α to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
    Li L; Liu M; Zhang T; Jia Y; Zhang Y; Yuan H; Zhang G; He C
    Scand J Gastroenterol; 2019 Jun; 54(6):793-799. PubMed ID: 31177924
    [No Abstract]   [Full Text] [Related]  

  • 7. Patient-related post-ERCP pancreatitis (PEP) risk factors between two groups of patients: Prophylactic pancreatic stent and rectal indomethacin.
    Ghalehnoei H; Hormati A; Mohammad Alizadeh AH; Ahmadpour S; Abedi SH
    Caspian J Intern Med; 2022; 13(4):728-734. PubMed ID: 36420331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cost-Effectiveness Analysis for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prophylaxis in the United States.
    Thiruvengadam NR; Saumoy M; Schneider Y; Attala S; Triggs J; Lee P; Kochman ML
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):216-226.e42. PubMed ID: 34481952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Lyu Y; Cheng Y; Wang B; Xu Y; Du W
    BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of fully covered metal stenting on the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis: A large multicenter study·.
    Xia MX; Zhou YF; Zhang M; Wang W; Wu J; Wang TT; Zhang XF; Hu B
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2256-2263. PubMed ID: 32473034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of low dose rectal diclofenac for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: Propensity score-matched analysis.
    Tomoda T; Kato H; Miyamoto K; Matsumi A; Ueta E; Fujii Y; Saragai Y; Yamazaki T; Uchida D; Matsumoto K; Horiguchi S; Tsutsumi K; Okada H
    Dig Endosc; 2021 May; 33(4):656-662. PubMed ID: 32881078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsteroidal anti-inflammatory drug effectivity in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis.
    Serrano JPR; Jukemura J; Romanini SG; Aguilar PFG; de Castro JSL; Torres IT; Pulla JAS; Neto OM; Taglieri E; Ardengh JC
    World J Gastrointest Endosc; 2020 Nov; 12(11):469-487. PubMed ID: 33269056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin Does Not Reduce Post-ERCP Pancreatitis in High-Risk Patients Receiving Pancreatic Stenting.
    Bai B; Wang S; Du Y; Li M; Huang Q; Liu S; Zhang C; Fang Y; Chen X; Hong J; Li Y; Xu Z; Liu X; Hong R; Bao J; Mei Q
    Dig Dis Sci; 2024 Jul; ():. PubMed ID: 39009916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in patients undergoing double-guidewire assisted biliary cannulation: A case-control study with propensity score matching.
    Wang X; Luo H; Luo B; Ren G; Liang S; Wang X; Tao Q; Zhang L; Kang X; Guo X; Pan Y
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1905-1912. PubMed ID: 33444486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of changing our cannulation method on the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis after pancreatic guidewire placement.
    Hisa T; Matsumoto R; Takamatsu M; Furutake M
    World J Gastroenterol; 2011 Dec; 17(48):5289-94. PubMed ID: 22219598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction.
    Siddiqui AA; Patel D; Kaplan J; Zabolotsky AH; Loren D; Kowalski T; Ghumman SS; Adler DG; Munigal S; Hayat U; Eloubeidi MA
    Dig Dis Sci; 2015 Aug; 60(8):2509-15. PubMed ID: 25868629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal Indomethacin and Spraying of Duodenal Papilla With Epinephrine Increases Risk of Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography.
    Luo H; Wang X; Zhang R; Liang S; Kang X; Zhang X; Lou Q; Xiong K; Yang J; Si L; Liu W; Liu Y; Zhou Y; Wang S; Yang M; Chen W; Han Y; Shang G; Yang X; He Y; Zou Q; Guo W; Dai Y; Zeng W; Zhu X; Gong R; Li X; Nie Z; Wang Q; Wang L; Pan Y; Guo X; Fan D
    Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1597-1606.e5. PubMed ID: 30391434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-World Practice Patterns in the Era of Rectal Indomethacin for Prophylaxis Against Post-ERCP Pancreatitis in a High-Risk Cohort.
    Smith ZL; Elmunzer BJ; Cooper GS; Chak A
    Am J Gastroenterol; 2020 Jun; 115(6):934-940. PubMed ID: 32496740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement.
    Choksi NS; Fogel EL; Cote GA; Romagnuolo J; Elta GH; Scheiman JM; Chak A; Mosler P; Higgins PD; Korsnes SJ; Schmidt SE; Sherman S; Lehman GA; Elmunzer BJ;
    Gastrointest Endosc; 2015 Jan; 81(1):150-5. PubMed ID: 25527053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.